Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Regen Biopharma Pfd A (RGBPP)

Regen Biopharma Pfd A (RGBPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0015 +153.33%
on 02/11/26
0.0300 -87.31%
on 01/20/26
-0.0157 (-80.56%)
since 01/09/26
3-Month
0.0015 +153.33%
on 02/11/26
0.0675 -94.37%
on 11/20/25
-0.0448 (-92.18%)
since 11/11/25
52-Week
0.0015 +153.33%
on 02/11/26
0.0950 -96.00%
on 10/28/25
-0.0298 (-88.67%)
since 02/11/25

Most Recent Stories

More News
Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025   

SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company will be presenting an update on its application for Orphan Drug...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company is in the process of addressing comments received by the U.S. Food...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma Explores Expanded Use of HemaXellerate for Chemotherapy-Induced Bone Marrow Suppression

Regen’s Approach Could Be Paradigm Shift in Supportive Oncology Care SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) today announced its ongoing efforts to...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market

SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of  HemaXellerate , the company’s...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product

An Orphan Drug Designation Could Provide Significant Benefits to Regen SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provides further insight...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerateâ„¢

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)
Regen BioPharma, Inc. Receives First Phase of Confirmatory Study

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its DuraCAR...

RGBP : 0.0015 (-37.50%)
RGBPP : 0.0038 (-45.71%)

Key Turning Points

3rd Resistance Point 0.0105
2nd Resistance Point 0.0083
1st Resistance Point 0.0060
Last Price 0.0038
1st Support Level 0.0015
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 0.0950
Fibonacci 61.8% 0.0593
Fibonacci 50% 0.0483
Fibonacci 38.2% 0.0372
Last Price 0.0038
52-Week Low 0.0015

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar